Expert Review of Hematology, Volume 16, Issue 10 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Hematology, Volume 16, Issue 10 (2023)

See all volumes and issues
Vol 17, 2024 Volume 16, 2023 Vol 15, 2022 Vol 14, 2021 Vol 13, 2020 Vol 12, 2019 Vol 11, 2018 Vol 10, 2017 Vol 9, 2016 Vol 8, 2015 Vol 7, 2014 Vol 6, 2013 Vol 5, 2012 Vol 4, 2011 Vol 3, 2010 Vol 2, 2009 Vol 1, 2008
Download citations Download PDFs Download issue

Editorial

Editorial
Next generation anticoagulants: a spotlight on the potential role of activated factors XII and XI
Helen Philippou & Evi X. Stavrou
Pages: 711-714
Published online: 10 Aug 2023
First Page PreviewforNext generation anticoagulants: a spotlight on the potential role of activated factors XII and XI | Full Text | References | PDF (182.9 KB) | EPUB
  • 831 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Review Article
Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors
Steven W. Pipe, Amy L. Dunn & Guy Young
Pages: 715-729
Published online: 21 Aug 2023
AbstractforEfficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitors | Full Text | References | PDF (2.2 MB) | EPUB
  • 1349 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Immune thrombocytopenia: a review on the pathogenetic role of immune cells
Forogh Nokhostin, Fatemeh Bakhshpour, Seyed Mohammad Sadegh Pezeshki, Reyhane Khademi & Najmaldin Saki
Pages: 731-742
Published online: 08 Sep 2023
AbstractforImmune thrombocytopenia: a review on the pathogenetic role of immune cells | Full Text | References | PDF (2.6 MB) | EPUB
  • 412 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Role of daratumumab in the frontline management of multiple myeloma: a narrative review
Sanjeev Yadav, Sadashivudu Gundeti, Abhay Bhave, Uttiya Deb, Jitendra Dixit & Kundan Mishra
Pages: 743-760
Published online: 18 Aug 2023
AbstractforRole of daratumumab in the frontline management of multiple myeloma: a narrative review | Full Text | References | PDF (1.3 MB) | EPUB
  • 2820 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Clinical status of induction therapy incorporating a hypomethylating agent for newly diagnosed adult acute myeloid leukemia compared to the standard 7+3 regimen
Akihiro Ohmoto & Shigeo Fuji
Pages: 761-771
Published online: 08 Sep 2023
AbstractforClinical status of induction therapy incorporating a hypomethylating agent for newly diagnosed adult acute myeloid leukemia compared to the standard 7+3 regimen | Full Text | References | PDF (475.2 KB) | EPUB | Supplemental
  • 232 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Modifiable lifestyle risk factors and survival after diagnosis with multiple myeloma
Simon Cheah, Julie K. Bassett, Fiona J. Bruinsma, John Hopper, Harindra Jayasekara, Doug Joshua, Robert J. MacInnis, H. Miles Prince, Melissa C. Southey, Claire M. Vajdic, Marina T. van Leeuwen, Nicole Wong Doo, Simon J. Harrison, Dallas R. English, Graham G. Giles & Roger L. Milne
Pages: 773-783
Published online: 08 Sep 2023
AbstractforModifiable lifestyle risk factors and survival after diagnosis with multiple myeloma | Full Text | References | PDF (684.9 KB) | EPUB | Supplemental
  • 162 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Trends of chronic lymphocytic leukemia incidence and mortality in the United States: a population-based study over the last four decades
Yousef Alabrach, Amir A. Mahmoud, Ali Abdelhay, Mohamad Mansour & Saryia Adra
Pages: 785-791
Published online: 01 Aug 2023
AbstractforTrends of chronic lymphocytic leukemia incidence and mortality in the United States: a population-based study over the last four decades | Full Text | References | PDF (930.7 KB) | EPUB
  • 121 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study
Robert F. Sidonio Jr, Alexis A. Thompson, Flora Peyvandi, Oleksandra Stasyshyn, Seoh Leng Yeoh, Darintr Sosothikul, Ali Bulent Antmen, Caterina Maggiore, Werner Engl, Bruce Ewenstein & Srilatha Tangada
Pages: 793-801
Published online: 07 Sep 2023
AbstractforImmunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A: interim results from a phase 3, prospective, multicenter, open-label study | Full Text | References | PDF (402.4 KB) | EPUB
  • 1700 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles